Skip to main content

$0.010 (0%)

High

$0.01

Low

$0.01

Trades

20

Turnover

$16,459

Volume

1,641,703
30 June 2023 at 4:10pm
Register to track PAB and receive email alerts.
Subject
PAB Ann: Paper highlights PAT-DX1 as potential brain cancer treatment

PAB Ann: Patrys receives R&D Tax Incentive refund

PAB Ann: Shareholder Newsletter - June 2021

PAB Ann: Patrys and Imagion collaborate on new cancer imaging agents

PAB Ann: S708A Cleansing Notice and Appendix 2A

PAB Ann: Appendix 4C - Quarterly - 31 March 2021

PAB Ann: Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies

PAB Ann: New United States patent granted for Patrys' deoxymab assets

PAB Ann: S708A Cleansing Notice and Appendix 2A

PAB Ann: Appendix 4D - Half Year Accounts - 31 December 2020

PAB Ann: Appendix 2A

PAB Ann: Patrys Successfully Establishes PAT-DX1 Stable Cell Line

PAB Ann: Appendix 4C - Quarterly - 31 December 2020

PAB Ann: Change of Director's Interest Notices x5

PAB Ann: Change in substantial holding

PAB Ann: S708A Cleansing Notice and Appendix 2A

PAB Ann: Appendix 3G

PAB Ann: Appendix 3G

PAB Ann: Change of Director's Interest Notices x2

PAB Ann: Appendix 2A - Options

PAB Ann: Appendix 2A - Shares

PAB Ann: Issue of Shortfall Securities

PAB Ann: S708A Cleansing Notice

PAB Ann: Appendix 2A - Options

PAB Ann: Appendix 2A - Shares

PAB Ann: Issue of Securities under Entitlement Offer

PAB Ann: Entitlement Offer Results and Shortfall Notification

PAB Ann: Poster Presentation at San Antonio Breast Cancer Symposium

PAB Ann: Market update

PAB Ann: Amended Constitution

PAB Ann: Results of Annual General Meeting

PAB Ann: Chairman's Address and CEO Presentation to 2020 AGM

PAB Ann: Dispatch of Offer Letter to Eligible Shareholders

PAB Ann: S708A Cleansing Notice and Appendix 2A

PAB Ann: Update to Indicative Timetable for Entitlement Offer

PAB Ann: Letter to Ineligible Shareholders

PAB Ann: Letter to Option holders - Entitlement Offer

PAB Ann: Letter to Eligible Shareholders - Entitlement Offer

PAB Ann: Entitlement Offer Prospectus

PAB Ann: Proposed issue of Securities - PAB

PAB Ann: $7.3M Capital Raising

PAB Ann: Investor Presentation - November 2020 - Updated

PAB Ann: Investor Presentation - November 2020

PAB Ann: Trading Halt

PAB Ann: Appendix 4C - Quarterly - 30 September 2020

PAB Ann: Response to ASX Price Query

PAB Ann: Notice of Annual General Meeting/Proxy Form

Register to track PAB and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX